Indraprastha Medical Corporation DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.74×	0.75×	0.74×	0.75×	0.74×
	1.11×	1.10×	1.08×	1.08×	1.05×
	15.0%	15.1%	14.7%	12.3%	10.1%
	1.61×	1.61×	1.72×	1.95×	1.98×
	1.37×	1.34×	1.43×	1.51×	1.46×
	27.3%	26.7%	29.1%	29.4%	22.7%
	27.5%	27.5%	30.0%	28.9%	22.7%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

INDRAMEDCO₹318.30

Indraprastha Medical Corporation Limited

· Pharma & Health

₹ CrorePeersARTEMISMED SHALBY GKSL GPTHEALTH LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹2,918 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.74	0.75	0.74	0.75	0.74
Interest Burden (Pretax/EBIT) ×	1.05	1.08	1.08	1.10	1.11
EBIT Margin %	10.14	12.31	14.74	15.06	14.99
Asset Turnover ×	1.98	1.95	1.72	1.61	1.61
Financial Leverage (Assets/Equity) ×	1.46	1.51	1.43	1.34	1.37
ROE (5-step product, year-end total equity) %	22.71	29.40	29.14	26.70	27.31
ROE (owners' profit / average owners' equity) %	22.70	28.92	29.97	27.47	27.47

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.